project id: TCGA-STAD; case submitter id: TCGA-R5-A7ZI; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.71; rna integrity number: 7.4; age at index: 44; days to birth: -16396; ethnicity: hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1965; age at diagnosis: 16396; ajcc pathologic m: M1; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2267.0; icd 10 code: C16.9; last known disease status: not reported; morphology: 8145/3; primary diagnosis: Carcinoma, diffuse type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Stomach, NOS; synchronous malignancy: No; tissue or organ of origin: Stomach, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 1679; days to sample procurement: 0; initial weight: 5.0; sample id: caf78613-93d3-4e62-9bf4-92524c8b206d; sample submitter id: TCGA-R5-A7ZI-01A; portion id: 01a40470-aec0-41db-81a6-428485f7dafa; portion submitter id: TCGA-R5-A7ZI-01A-11; slide id: 3a4a56f1-1cfd-441d-85f3-52dda0b346a5; slide submitter id: TCGA-R5-A7ZI-01Z-00-DX1; percent lymphocyte infiltration: 6.0; percent monocyte infiltration: 3.0; percent necrosis: 15.0; percent neutrophil infiltration: 8.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 65.0; percent tumor nuclei: 80.0; section location: TOP;